Lenox Wealth Advisors’s Labcorp LH Stock Holding History

Lenox Wealth Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$10K	Sell	43 -2	-4%	-$470	﹤0.01%	486
2021 Q4	$12K	Hold	45	–	–	﹤0.01%	487
2021 Q3	$11K	Buy	45 +2	+5%	+$504	﹤0.01%	455
2021 Q2	$10K	Buy	+43	New	+$9.8K	﹤0.01%	476
2020 Q2	–	Sell	-69	Closed	-$7K	–	705
2020 Q1	$7K	Buy	+69	New	+$9.94K	﹤0.01%	385
2018 Q3	–	Sell	-59	Closed	-$9K	–	474
2018 Q2	$9K	Sell	59 -19	-24%	-$2.87K	﹤0.01%	382
2018 Q1	$11K	Buy	78 +59	+311%	+$8.67K	﹤0.01%	347
2017 Q4	$3K	Buy	+19	New	+$2.51K	﹤0.01%	288
2016 Q1	–	Sell	-30	Closed	-$3K	–	339
2015 Q4	$3K	Buy	+30	New	+$3.1K	﹤0.01%	282

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lenox Wealth Advisors's LH Position: Q1 2022 in Review

Lenox Wealth Advisors reduced its Labcorp (LH) stake by 4.4% in Q1 2022, selling an estimated $470 and leaving 43 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #486.

Lenox Wealth Advisors first reported a position in LH in Q4 2015 and has held it in 9 quarters since. The position peaked at $12K in Q4 2021. 1,034 funds tracked by Wall St. Rank hold LH as of Q1 2022.

Lenox Wealth Advisors held 43 shares of Labcorp worth $10K as of Q1 2022.
Lenox Wealth Advisors sold 2 Labcorp shares in Q1 2022, an estimated $470.
Labcorp made up ﹤0.01% of Lenox Wealth Advisors's portfolio in Q1 2022, its #486 holding.
Lenox Wealth Advisors first reported a position in Labcorp in Q4 2015 and has held it in 9 quarters since.
Lenox Wealth Advisors's Labcorp position peaked at $12K in Q4 2021.
1,034 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.